Literature DB >> 21274375

Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis.

David Philippe1, Laurent Favre, Francis Foata, Oskar Adolfsson, Genevieve Perruisseau-Carrier, Karine Vidal, Gloria Reuteler, Johanna Dayer-Schneider, Christoph Mueller, Stéphanie Blum.   

Abstract

AIM: To assess the anti-inflammatory effect of the probiotic Bifidobacterium lactis (B. lactis) in an adoptive transfer model of colitis.
METHODS: Donor and recipient mice received either B. lactis or bacterial culture medium as control (deMan Rogosa Sharpe) in drinking water for one week prior to transfer of a mix of naive and regulatory T cells until sacrifice.
RESULTS: All recipient mice developed signs of colonic inflammation, but a significant reduction of weight loss was observed in B. lactis-fed recipient mice compared to control mice. Moreover, a trend toward a diminution of mucosal thickness and attenuated epithelial damage was revealed. Colonic expression of pro-inflammatory and T cell markers was significantly reduced in B. lactis-fed recipient mice compared to controls. Concomitantly, forkhead box protein 3, a marker of regulatory T cells, was significantly up-regulated by B. lactis.
CONCLUSION: Daily oral administration of B. lactis was able to reduce inflammatory and T cells mediators and to promote regulatory T cells specific markers in a mouse model of colitis.

Entities:  

Keywords:  Adoptive transfer model; Bifidobacterium; Colitis; Inflammation; Mice; Probiotics; Regulatory T cells

Mesh:

Substances:

Year:  2011        PMID: 21274375      PMCID: PMC3027012          DOI: 10.3748/wjg.v17.i4.459

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  68 in total

Review 1.  Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.

Authors:  R S Blumberg; L J Saubermann; W Strober
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

2.  Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.

Authors:  Z Liu; K Geboes; S Colpaert; L Overbergh; C Mathieu; H Heremans; M de Boer; L Boon; G D'Haens; P Rutgeerts; J L Ceuppens
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

Review 3.  Role of cytokines in the pathogenesis of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

4.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

Authors:  H C Rath; H H Herfarth; J S Ikeda; W B Grenther; T E Hamm; E Balish; J D Taurog; R E Hammer; K H Wilson; R B Sartor
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 5.  Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

Authors:  R B Sartor
Journal:  Gastroenterol Clin North Am       Date:  1995-09       Impact factor: 3.806

6.  The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.

Authors:  Jonas Mudter; Lioubov Amoussina; Mirjam Schenk; Jingling Yu; Anne Brüstle; Benno Weigmann; Raja Atreya; Stefan Wirtz; Christoph Becker; Arthur Hoffman; Imke Atreya; Stefan Biesterfeld; Peter R Galle; Hans A Lehr; Stefan Rose-John; Christoph Mueller; Michael Lohoff; Markus F Neurath
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

Review 7.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

Authors:  Dmitry V Ostanin; Jianxiong Bao; Iurii Koboziev; Laura Gray; Sherry A Robinson-Jackson; Melissa Kosloski-Davidson; V Hugh Price; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

Review 8.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

9.  Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells.

Authors:  Annamaria Pronio; Chiara Montesani; Cinzia Butteroni; Simona Vecchione; Gloria Mumolo; AnnaRita Vestri; Domenico Vitolo; Monica Boirivant
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

10.  Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells.

Authors:  N Corazza; S Eichenberger; H P Eugster; C Mueller
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

View more
  22 in total

1.  The commensal microbiota exacerbate infectious colitis in stressor-exposed mice.

Authors:  Jeffrey D Galley; Nicola M Parry; Brian M M Ahmer; James G Fox; Michael T Bailey
Journal:  Brain Behav Immun       Date:  2016-09-12       Impact factor: 7.217

2.  Insulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patients.

Authors:  Isabel Moreno-Indias; Lidia Sánchez-Alcoholado; Eduardo García-Fuentes; Fernando Cardona; Maria Isabel Queipo-Ortuño; Francisco J Tinahones
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Mesenchymal stromal cells modulate gut inflammation in experimental colitis.

Authors:  Cristhiane Favero de Aguiar; Angela Castoldi; Vinícius Andrade-Oliveira; Aline Ignacio; Flávia Franco da Cunha; Raphael José Ferreira Felizardo; Ênio José Bassi; Niels Olsen Saraiva Câmara; Danilo Candido de Almeida
Journal:  Inflammopharmacology       Date:  2017-10-23       Impact factor: 4.473

4.  Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.

Authors:  Guoyan Zhao; Tommi Vatanen; Lindsay Droit; Arnold Park; Aleksandar D Kostic; Tiffany W Poon; Hera Vlamakis; Heli Siljander; Taina Härkönen; Anu-Maaria Hämäläinen; Aleksandr Peet; Vallo Tillmann; Jorma Ilonen; David Wang; Mikael Knip; Ramnik J Xavier; Herbert W Virgin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

5.  Consumption of Bifidobacterium animalis subsp. lactis BB-12 in yogurt reduced expression of TLR-2 on peripheral blood-derived monocytes and pro-inflammatory cytokine secretion in young adults.

Authors:  Huicui Meng; Zhaoyong Ba; Yujin Lee; Jiayu Peng; Junli Lin; Jennifer A Fleming; Emily J Furumoto; Robert F Roberts; Penny M Kris-Etherton; Connie J Rogers
Journal:  Eur J Nutr       Date:  2015-11-30       Impact factor: 5.614

6.  Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons.

Authors:  Sonia A Ballal; Patrick Veiga; Kathrin Fenn; Monia Michaud; Jason H Kim; Carey Ann Gallini; Jonathan N Glickman; Gaëlle Quéré; Peggy Garault; Chloé Béal; Muriel Derrien; Pascal Courtin; Saulius Kulakauskas; Marie-Pierre Chapot-Chartier; Johan van Hylckama Vlieg; Wendy S Garrett
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

7.  Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage.

Authors:  Luca D Prisciandaro; Mark S Geier; Ann E Chua; Ross N Butler; Adrian G Cummins; Guy R Sander; Gordon S Howarth
Journal:  Support Care Cancer       Date:  2012-04-20       Impact factor: 3.603

8.  Anti-inflammatory effects of Lacto-Wolfberry in a mouse model of experimental colitis.

Authors:  David Philippe; Viral Brahmbhatt; Francis Foata; Yen Saudan; Patrick Serrant; Stephanie Blum; Jalil Benyacoub; Karine Vidal
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

9.  Probiotics and Innate and Adaptive Immune Responses in Premature Infants.

Authors:  Mark A Underwood
Journal:  For Immunopathol Dis Therap       Date:  2016

10.  Interleukin-10 gene-carrying bifidobacteria ameliorate murine ulcerative colitis by regulating regulatory T cell/T helper 17 cell pathway.

Authors:  Dingguo Zhang; Cheng Wei; Jun Yao; Xiaoyan Cai; Lisheng Wang
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.